1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-38.74%
Negative gross profit growth while FSLR is at 84.86%. Joel Greenblatt would examine cost competitiveness or demand decline.
-444.62%
Negative EBIT growth while FSLR is at 160.68%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-279.01%
Negative operating income growth while FSLR is at 160.68%. Joel Greenblatt would press for urgent turnaround measures.
-817.67%
Negative net income growth while FSLR stands at 663.87%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-825.00%
Negative EPS growth while FSLR is at 664.97%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-825.00%
Negative diluted EPS growth while FSLR is at 664.97%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.17%
Share count expansion well above FSLR's 0.06%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.56%
Reduced diluted shares while FSLR is at 0.51%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-1062.88%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-493.32%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-52.73%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-9.62%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.06%
Negative 3Y CAGR while FSLR stands at 1.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-155.15%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
53.48%
5Y OCF/share CAGR above 1.5x FSLR's 25.12%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
27.20%
3Y OCF/share CAGR under 50% of FSLR's 93.22%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
31.95%
Positive 10Y CAGR while FSLR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
62.15%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
-3593.20%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-63.50%
Negative equity/share CAGR over 10 years while FSLR stands at 30.58%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-15.41%
Negative 5Y equity/share growth while FSLR is at 11.48%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
5052.45%
3Y equity/share CAGR above 1.5x FSLR's 12.40%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.77%
Our AR growth while FSLR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
20.53%
Inventory growth well above FSLR's 20.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-16.16%
Negative asset growth while FSLR invests at 3.80%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-12.72%
We have a declining book value while FSLR shows 0.49%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.99%
We’re deleveraging while FSLR stands at 65.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
30.34%
We increase R&D while FSLR cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
10.61%
SG&A growth well above FSLR's 3.03%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.